160 related articles for article (PubMed ID: 22160518)
1. Identification of potential serum biomarkers for Wilms tumor after excluding confounding effects of common systemic inflammatory factors.
Wang J; Wang L; Zhang D; Fan Y; Jia Z; Qin P; Yu J; Zheng S; Yang F
Mol Biol Rep; 2012 May; 39(5):5095-104. PubMed ID: 22160518
[TBL] [Abstract][Full Text] [Related]
2. Identification of apolipoprotein C-I as a potential Wilms' tumor marker after excluding inflammatory factors.
Zhang J; Guo F; Wang L; Zhao W; Zhang D; Yang H; Yu J; Niu L; Yang F; Zheng S; Wang J
Int J Mol Sci; 2014 Sep; 15(9):16186-95. PubMed ID: 25222555
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel serum biomarkers in child nephroblastoma using proteomics technology.
Zhang Q; Wang J; Dong R; Yang S; Zheng S
Mol Biol Rep; 2011 Jan; 38(1):631-8. PubMed ID: 20369385
[TBL] [Abstract][Full Text] [Related]
4. [Screening and identification analysis of serum protein biomarkers in nephroblastoma].
Wang JX; Yang SB; Liu QL; Dong R; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1259-63. PubMed ID: 19595180
[TBL] [Abstract][Full Text] [Related]
5. Screening and identification of non-inflammatory specific protein markers in Wilms' tumor tissues.
Zhang J; Guo F; Wang L; Zhao W; Zhang D; Yang H; Yu J; Niu L; Yang F; Zheng S; Wang J
Arch Biochem Biophys; 2019 Nov; 676():108112. PubMed ID: 31550443
[TBL] [Abstract][Full Text] [Related]
6. Discovery and identification of serum biomarkers of Wilms' tumor in mice using proteomics technology.
Jia ZK; Wang JX; Yang JJ; Xue R; Zhang D; Wang GN; Ma SL; Duan ZF
Chin Med J (Engl); 2012 May; 125(10):1727-32. PubMed ID: 22800891
[TBL] [Abstract][Full Text] [Related]
7. Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.
Zhao W; Li J; Zhang J; Gao P; Pei H; Wang L; Guo F; Yu J; Zheng S; Wang J
Int J Mol Sci; 2015 Jun; 16(6):12669-85. PubMed ID: 26053398
[TBL] [Abstract][Full Text] [Related]
8. New serum biomarkers for detection of endometriosis using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Zheng N; Pan C; Liu W
J Int Med Res; 2011; 39(4):1184-92. PubMed ID: 21986120
[TBL] [Abstract][Full Text] [Related]
9. New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Guo R; Pan C; Shen J; Liu C
J Cancer Res Clin Oncol; 2011 Mar; 137(3):513-9. PubMed ID: 20490864
[TBL] [Abstract][Full Text] [Related]
10. Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological study.
Liao CC; Mehta A; Ward NJ; Marsh S; Arulampalam T; Norton JD
World J Surg Oncol; 2010 Apr; 8():33. PubMed ID: 20420661
[TBL] [Abstract][Full Text] [Related]
11. [Detecting biomarkers from serum in nephroblastoma patients with support vector machine].
Wang JX; Zhang J; Liu QL; Wang L; Fan YZ; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2982-5. PubMed ID: 17288811
[TBL] [Abstract][Full Text] [Related]
12. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches.
Zhang LY; Ying WT; Mao YS; He HZ; Liu Y; Wang HX; Liu F; Wang K; Zhang DC; Wang Y; Wu M; Qian XH; Zhao XH
World J Gastroenterol; 2003 Apr; 9(4):650-4. PubMed ID: 12679903
[TBL] [Abstract][Full Text] [Related]
13. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
[TBL] [Abstract][Full Text] [Related]
14. Discovery and identification of potential biomarkers of papillary thyroid carcinoma.
Fan Y; Shi L; Liu Q; Dong R; Zhang Q; Yang S; Fan Y; Yang H; Wu P; Yu J; Zheng S; Yang F; Wang J
Mol Cancer; 2009 Sep; 8():79. PubMed ID: 19785722
[TBL] [Abstract][Full Text] [Related]
15. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
[TBL] [Abstract][Full Text] [Related]
16. [Preliminarily screening of serum characteristic markers in acute myeloid leukemia and clinical significance].
He AL; Bai J; Huang C; Zhang WG; Yang J; Wang JL; Meng X; Tian W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1132-7. PubMed ID: 21129246
[TBL] [Abstract][Full Text] [Related]
17. Purification, identification and profiling of serum amyloid A proteins from sera of advanced-stage cancer patients.
Li J; Xie Z; Shi L; Zhao Z; Hou J; Chen X; Cui Z; Xue P; Cai T; Wu P; Guo S; Yang F
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():3-9. PubMed ID: 22341353
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples.
Bloomston M; Zhou JX; Rosemurgy AS; Frankel W; Muro-Cacho CA; Yeatman TJ
Cancer Res; 2006 Mar; 66(5):2592-9. PubMed ID: 16510577
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenoma biomarkers identified using proteomic fingerprint technology.
Zhou KY; Jin HH; Bai ZQ; Liu CB
Asian Pac J Cancer Prev; 2012; 13(8):4093-5. PubMed ID: 23098522
[TBL] [Abstract][Full Text] [Related]
20. Sera of children with renal tumours contain low-molecular-mass hyaluronic acid.
Kumar S; West DC; Ponting JM; Gattamaneni HR
Int J Cancer; 1989 Sep; 44(3):445-8. PubMed ID: 2550372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
